AU2003213718A8 - Method of producing antigens - Google Patents

Method of producing antigens

Info

Publication number
AU2003213718A8
AU2003213718A8 AU2003213718A AU2003213718A AU2003213718A8 AU 2003213718 A8 AU2003213718 A8 AU 2003213718A8 AU 2003213718 A AU2003213718 A AU 2003213718A AU 2003213718 A AU2003213718 A AU 2003213718A AU 2003213718 A8 AU2003213718 A8 AU 2003213718A8
Authority
AU
Australia
Prior art keywords
producing antigens
antigens
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003213718A
Other versions
AU2003213718A1 (en
Inventor
Szu-Yi Chou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHOU SZU YI
Original Assignee
CHOU SZU YI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/231,063 external-priority patent/US20030224476A1/en
Priority claimed from US10/231,298 external-priority patent/US20030219853A1/en
Priority claimed from US10/231,213 external-priority patent/US20040001848A1/en
Priority claimed from US10/231,114 external-priority patent/US7485438B2/en
Priority claimed from US10/231,470 external-priority patent/US7101695B2/en
Application filed by CHOU SZU YI filed Critical CHOU SZU YI
Publication of AU2003213718A8 publication Critical patent/AU2003213718A8/en
Publication of AU2003213718A1 publication Critical patent/AU2003213718A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003213718A 2002-03-01 2003-03-03 Method of producing antigens Abandoned AU2003213718A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US36116602P 2002-03-01 2002-03-01
US60/361,166 2002-03-01
US36344502P 2002-03-08 2002-03-08
US60/363,445 2002-03-08
US10/231,063 US20030224476A1 (en) 2002-03-01 2002-08-28 Method of producing transglutaminase reactive compound
US10/231,298 US20030219853A1 (en) 2002-03-01 2002-08-28 Method of cross-linking a compound
US10/231,213 US20040001848A1 (en) 2002-03-01 2002-08-28 Method of producing disease-specific antigens
US10/231,114 US7485438B2 (en) 2002-03-01 2002-08-28 Method of producing polyvalent antigens
US10/231,063 2002-08-28
US10/231,298 2002-08-28
US10/231,470 2002-08-28
US10/231,114 2002-08-28
US10/231,470 US7101695B2 (en) 2002-03-01 2002-08-28 Method of producing transglutaminase having broad substrate activity
US10/231,213 2002-08-28
PCT/US2003/006661 WO2003074004A2 (en) 2002-03-01 2003-03-03 Method of producing antigens

Publications (2)

Publication Number Publication Date
AU2003213718A8 true AU2003213718A8 (en) 2003-09-16
AU2003213718A1 AU2003213718A1 (en) 2003-09-16

Family

ID=27792403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213718A Abandoned AU2003213718A1 (en) 2002-03-01 2003-03-03 Method of producing antigens

Country Status (2)

Country Link
AU (1) AU2003213718A1 (en)
WO (1) WO2003074004A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
WO2005072777A2 (en) * 2004-01-28 2005-08-11 Curix Aps Conjugates of amyloid proteins as vaccines for amyloid-related diseases
TW200726482A (en) * 2005-06-30 2007-07-16 Merck & Co Inc Method for preparing a covalently cross linked oligomer of amyloid beta peptides
RU2432362C2 (en) 2005-11-30 2011-10-27 Эбботт Лэборетриз Monoclonal antibodies and applications thereof
BRPI0619249A2 (en) 2005-11-30 2011-09-20 Abbott Lab anti-globulin-ß antibodies, antigen-binding fractions thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of making said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
CN101506233A (en) * 2006-08-18 2009-08-12 诺沃-诺迪斯克保健股份有限公司 Transglutaminase variants with improved specificity
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
CN103933606B (en) 2006-12-15 2016-08-24 生命连结有限公司 Gelatin-transglutaminase hemostatic dressings and encapsulant
WO2008102007A1 (en) * 2007-02-22 2008-08-28 Novo Nordisk Health Care Ag Transglutaminase variants with improved specificity
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
CN104031393B (en) 2008-06-18 2017-08-01 生命连结有限公司 Improved cross-linked composition
US20110086014A1 (en) * 2008-06-18 2011-04-14 Ishay Attar Method for enzymatic cross-linking of a protein
CA2782863A1 (en) 2009-12-22 2011-06-30 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
US8961544B2 (en) 2010-08-05 2015-02-24 Lifebond Ltd. Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix
WO2012024187A1 (en) 2010-08-14 2012-02-23 Abbott Laboratories Amyloid-beta binding proteins
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544638A (en) * 1984-05-18 1985-10-01 The Regents Of The University Of California Synthesis of cross-links in the helical domain of collagen using pyridoxal 5-phosphate and copper or iron
WO1996010089A1 (en) * 1994-09-29 1996-04-04 Ajinomoto Co., Inc. Modification of peptide and protein

Also Published As

Publication number Publication date
WO2003074004A3 (en) 2006-08-10
AU2003213718A1 (en) 2003-09-16
WO2003074004A2 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
EP1514928A4 (en) Method for producing antibodies
AU2003205507A8 (en) Method of producing fabric
AU2003248563A1 (en) Method of forming nanocrystals
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
AU2003234419A8 (en) Method of forming manofluidic channels
PL374600A1 (en) Method of producing honeycomb structures
AU2003213718A8 (en) Method of producing antigens
EP1516858A4 (en) Method of producing flat glass
EP1541721A4 (en) Method of producing silicon monocrystal
EP1577280A4 (en) Method of deuterization
PL355161A1 (en) Method of manufacture
EP1437326A4 (en) METHOD FOR PRODUCING Si
GB2387599B (en) Methods for producing antibodies
TWI347932B (en) Producing method of purified 2-cyanoacrylates
EP1374834A4 (en) Method of producing cosmetics-impregnated sheet
GB0504677D0 (en) Method of creating antigens using emus
AU2003246225A1 (en) Method of producing mold
EP1556396A4 (en) Method for producing 2-deoxy-l-ribose
AU2003217706A8 (en) Methods of producing phosphitylated compounds
AU2003276825A8 (en) Method of immunotherapy
AU2003222584A1 (en) Method of producing organoacyloxysilanes
PL372169A1 (en) Method for producing gelatin
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
PL355859A1 (en) Method of manufacture of ornaments
HUP0302540A3 (en) Method of producing 1-alkyl-3-aryl-5-difluoromethoxy-1h-pyrazoles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase